Foresite Capital Management IV, LLC Diversified Active

Name: Foresite Capital Management IV, LLC Q3 2018 13F Filing | 13F Explorer
Creator: Foresite Capital Management IV, LLC
Published: 2018-11-13

Location: West Hollywood, CA

CIK: 0001704132 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 13, 2018

Total Value: $305M (100.0% shares, 0.0% debt)

Holdings (21)

INSM Insmed Incorporated 11.9%

Value $36.41M Shares 1,800,587 Est. Cost $27.89 Unrealized -18.9%

— Myokardia, Inc. 10.9%

Value $33.33M Shares 511,244 Est. Cost $45.40 Unrealized —

— Biohaven Pharmaceutical Holding Company Ltd. 10.5%

Value $31.96M Shares 851,200 Est. Cost $26.07 Unrealized —

— Immunomedics, Inc. 8.4%

Value $25.65M Shares 1,231,543 Est. Cost $17.13 Unrealized —

ABUS Arbutus Biopharma Corporation 8.3%

Value $25.3M Shares 2,676,825 Est. Cost $5.62 Unrealized +76.8%

— CymaBay Therapeutics, Inc. 7.4%

Value $22.42M Shares 2,023,369 Est. Cost $9.20 Unrealized —

RYTM Rhythm Pharmaceuticals, Inc. 6.7%

Value $20.33M Shares 696,903 Est. Cost $27.09 Unrealized +16.7%

REPL Replimune Group, Inc. 6.5%

Value $19.8M Shares 1,229,656 Est. Cost $17.53 Unrealized 0.0%

— OptiNose, Inc. 5.9%

Value $18.13M Shares 1,458,545 Est. Cost $19.34 Unrealized —

ASND Ascendis Pharma A/S 5.7%

Value $17.39M Shares 245,424 Est. Cost $40.06 Unrealized —

— Alder BioPharmaceuticals, Inc. 5.5%

Value $16.66M Shares 1,000,919 Est. Cost $13.27 Unrealized —

OMER Omeros Corp. 2.8%

Value $8.69M Shares 356,000 Est. Cost $22.30 Unrealized 0.0%

ACRS Aclaris Therapeutics, Inc. 2.5%

Value $7.689M Shares 529,551 Est. Cost $22.18 Unrealized -22.7%

— Eidos Therapeutics, Inc. 1.7%

Value $5.24M Shares 525,000 Est. Cost $14.82 Unrealized —

XENE Xenon Pharmaceuticals, Inc. 1.7%

Value $5.091M Shares 385,714 Est. Cost $11.59 Unrealized 0.0%

RCUS Arcus Biosciences, Inc. 1.3%

Value $4.112M Shares 295,000 Est. Cost $16.66 Unrealized -23.4%

— Gritstone Oncology, Inc. 0.8%

Value $2.492M Shares 175,000 Est. Cost $14.24 Unrealized —

— Kiniksa Pharmaceuticals, Ltd. 0.8%

Value $2.409M Shares 94,477 Est. Cost $17.35 Unrealized —

CRNX Crinetics Pharmaceuticals, Inc. 0.5%

Value $1.421M Shares 49,600 Est. Cost $29.69 Unrealized 0.0%

QURE uniQure N.V. 0.1%

Value $388K Shares 10,650 Est. Cost $15.23 Unrealized +144.3%

— Verona Pharma Plc 0.0%

Value $104K Shares 8,302 Est. Cost $12.53 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
INSM	Insmed Incorporated	1,800,587	$36.41M	11.9%	$27.89	-18.9%	COM	457669307
—	Myokardia, Inc.	511,244	$33.33M	10.9%	$45.40	—	COM	62857M105
—	Biohaven Pharmaceutical Holding Company Ltd.	851,200	$31.96M	10.5%	$26.07	—	COM	G11196105
—	Immunomedics, Inc.	1,231,543	$25.65M	8.4%	$17.13	—	COM	452907108
ABUS	Arbutus Biopharma Corporation	2,676,825	$25.3M	8.3%	$5.62	+76.8%	COM	03879J100
—	CymaBay Therapeutics, Inc.	2,023,369	$22.42M	7.4%	$9.20	—	COM	23257D103
RYTM	Rhythm Pharmaceuticals, Inc.	696,903	$20.33M	6.7%	$27.09	+16.7%	COM	76243J105
REPL	Replimune Group, Inc.	1,229,656	$19.8M	6.5%	$17.53	0.0%	COM	76029N106
—	OptiNose, Inc.	1,458,545	$18.13M	5.9%	$19.34	—	COM	68404V100
ASND	Ascendis Pharma A/S	245,424	$17.39M	5.7%	$40.06	—	SPONSORED ADR	04351P101
—	Alder BioPharmaceuticals, Inc.	1,000,919	$16.66M	5.5%	$13.27	—	COM	014339105
OMER	Omeros Corp.	356,000	$8.69M	2.8%	$22.30	0.0%	COM	682143102
ACRS	Aclaris Therapeutics, Inc.	529,551	$7.689M	2.5%	$22.18	-22.7%	COM	00461U105
—	Eidos Therapeutics, Inc.	525,000	$5.24M	1.7%	$14.82	—	COM	28249H104
XENE	Xenon Pharmaceuticals, Inc.	385,714	$5.091M	1.7%	$11.59	0.0%	COM	98420N105
RCUS	Arcus Biosciences, Inc.	295,000	$4.112M	1.3%	$16.66	-23.4%	COM	03969F109
—	Gritstone Oncology, Inc.	175,000	$2.492M	0.8%	$14.24	—	COM	39868T105
—	Kiniksa Pharmaceuticals, Ltd.	94,477	$2.409M	0.8%	$17.35	—	Class A Common	G5269C101
CRNX	Crinetics Pharmaceuticals, Inc.	49,600	$1.421M	0.5%	$29.69	0.0%	COM	22663K107
QURE	uniQure N.V.	10,650	$388K	0.1%	$15.23	+144.3%	SHS	N90064101
—	Verona Pharma Plc	8,302	$104K	0.0%	$12.53	—	SPONSORED ADS	925050106